Guerbet is a pharmaceutical company focused on medical imaging. It develops and supplies contrast agents used in X-ray, magnetic resonance imaging and ultrasound examinations, along with injection systems and related products that help clinicians obtain clearer images of the body. Its customers are hospitals, imaging centres and healthcare professionals who use these products in diagnostic procedures. The company is based in France and serves medical imaging markets in many countries around the world.
Guerbet trades under the code 0ELV on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #3744 of 3787 on the London Exchange · confidence Medium
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
4/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-46.5%
From 52-week high-67.8%
MomentumWeak
6/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-35.8%
6-month return-41.9%
12-month, skipping last month-51.1%
Stability (higher is calmer)Weak
12/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)66.5%
Worst drawdown, 1 year (smaller is calmer)-70.3%
LiquidityWeak
5/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.00M EUR
Zero-volume days16.7%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends3
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 5.820 – 18.130Daily closes, split-adjusted
Signals
50-day average7.515
200-day average10.888
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.106
Technical summary
Daily
Bearish
4 bullish · 0 neutral · 12 bearish
Weekly
Strongly bearish
1 bullish · 0 neutral · 11 bearish
Monthly
Strongly bearish
1 bullish · 0 neutral · 7 bearish
Moving averages (daily)
SMA 10
6.21
Bearish
EMA 10
6.20
Bearish
SMA 20
6.65
Bearish
EMA 20
6.58
Bearish
SMA 50
7.52
Bearish
EMA 50
7.41
Bearish
SMA 100
8.63
Bearish
EMA 100
8.62
Bearish
SMA 200
10.89
Bearish
EMA 200
11.38
Bearish
Oscillators (daily)
RSI (14)
10.54
Bullish
MACD (12, 26)
-0.49
Bearish
Momentum (12)
-13.91
Bearish
Stochastic %K (14)
0.00
Bullish
Williams %R (14)
-100.0
Bullish
CCI (20)
-126.0
Bullish
Pivot points (classic, last session)
S3
5.82
S2
5.82
S1
5.82
Pivot
5.82
R1
5.82
R2
5.82
R3
5.82
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
0.00 EUR
Yield on today's price
–
Frequency
None in the last year
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
0.5000
0.5000
0.8500
0.7000
0.7000
0.8500
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in EUR. Educational only, not financial advice.
